|
|
Volumn 373, Issue 9678, 2009, Pages 1846-1848
|
|
Prasugrel STEMI subgroup analysis - Authors' reply
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
BIOLOGICAL MARKER;
CLOPIDOGREL;
HEART ENZYME;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PRASUGREL;
ANTITHROMBOCYTIC AGENT;
DRUG DERIVATIVE;
PIPERAZINE DERIVATIVE;
THIOPHENE DERIVATIVE;
TICLOPIDINE;
BLEEDING;
CORONARY ARTERY BYPASS GRAFT;
DRUG EFFICACY;
ELECTROCARDIOGRAM;
EVIDENCE BASED MEDICINE;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL ABSORPTION;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
IMAGING;
LETTER;
LOADING DRUG DOSE;
MEDICAL RECORD REVIEW;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
RANDOMIZATION;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
THROMBOCYTE FUNCTION;
METHODOLOGY;
MORTALITY;
NOTE;
DRUG ADMINISTRATION;
ELECTROCARDIOGRAPHY;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
ASPIRIN;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MYOCARDIAL INFARCTION;
PIPERAZINES;
PLATELET AGGREGATION INHIBITORS;
RESEARCH DESIGN;
THIOPHENES;
TICLOPIDINE;
DATA INTERPRETATION, STATISTICAL;
DRUG ADMINISTRATION SCHEDULE;
ELECTROCARDIOGRAPHY;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
|
|
EID: 65849130088
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(09)61022-9 Document Type: Letter |
|
Times cited : (2)
|
|
References (5)
|
